Ramachandran Niro Ph.D 4
4 · Akoya Biosciences, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Ramachandran Niro Ph.D
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-03-01$1.63/sh−2,310$3,765→ 293,114 total - Tax Payment
Common Stock
2025-03-01$1.63/sh−3,594$5,858→ 289,520 total
Footnotes (2)
- [F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 23, 2023, which vests in four (4) annual equal installments beginning on March 1, 2024 and annually thereafter until fully vested.
- [F2]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 22, 2024, which vests in four (4) annual equal installments beginning on March 1, 2025 and annually thereafter until fully vested.